The Subject Expert Committee (SEC) has recommended phase 1 clinical trials of Reliance Life Sciences’ vaccine candidate against the coronavirus disease (Covid-19), press agency ANI reported on Friday. The proposed vaccine candidate comprises two doses, and is predicated on recombinant protein platform, as per reports. Now that the SEC has recommended phase 1 trials, subsequent […]